Mary Beth Pfeiffer profiles Midwestern Doctor’s viral series, Ecuador spinal recovery, and FDA history.

Unbekoming announces paperbacks arguing cheap, versatile molecules face structural suppression—DMSO as exhibit A.

Vigilant Fox editorializes Midwestern Doctor’s stroke/SCI DMSO report for a general audience—dramatic cases plus safety claims.

Vigilant Fox packages AMD’s ENT/dental DMSO review—vision, tinnitus, sinus, and gum anecdotes with a strong suppression narrative.

Vigilant Fox popularizes DMSO differentiation science and the hematoxylin combination narrative for a general audience.

VF highlights ARDS IV DMSO anecdotes and organ-protection literature spanning heart, gut, liver, kidney, pancreas, and GU tract.

Robert Yoho, MD compiles decades of DMSO research into a readable book: history, safety claims, organ systems, and why he says an unpatentable solvent was sidelined.

Midwestern Doctor’s open thread explains using AI as a summarization tool—not a ghostwriter—to compile DMSO literature.

TrialSite News headlines DMSO’s renewed public interest; full body was thin on fetch.

From paper-mill byproduct to 60 Minutes headline: a Vigilant Fox summary of how DMSO rose, faced FDA limits, and lived on in patient networks and overseas clinics.